ING THINK
Japan: Asia’s Europe?
ASIA/PACIFIC: Japan mirrors Europe’s pharma challenge: it is an important biopharmaceutical innovation market historically. However, in recent years its share of global drug approvals and clinical trials has declined. An ageing population, limited capital markets depth, conservat
Desk synthesis pending
We’re writing the institutional analysis for this note — multi-section body, firm-by-firm alignment chips, key takeaways, market implications, risks. The synthesizer processes the queue hourly, with priority by citation density.